ASA ( wait for pilot study) physical status I-
Conditions
Interventions
and informed consent will be obtained from them. Patients will be excluded from the study if they refuse to receive intervention,
have allergy to the drug under study,
have diabetes mellitus,
preexist coagulation disorders,
are morbid obesity,
have local infection at the site of the block,
have chronic pain,
receive medical therapies considered to result in tolerance to opiates,
After the study protocal is approved by Khon Kaen Hospital Institute Review Board in Human Research (KIRB) and registered on clinical trials. All ASA I-
II patients between ages of 18 and 75 undergoing upper extremity surgery (elective or emergency) will be identified,
cannot evaluate numerical rating scale and use systemic corticosteroids more than 20 mg/day for 5 days or longer within 12 months and Has systemic infection such as Tuberculosis or viral infection.
B
patient’s fasting blood sugar will be checked and patients will be instructed about the use of the NRS for pain assessment on 0-
10 (0=no pain,
10=worst pain imaginable).
Using a computer generated randomization by STATA 10,
patients will be randomized in three-
treatment groups:
Group 1 Control (Gr.C): receive 2% lidocaine with adrenaline 1:200,
000 7mg/kg (maximum 20 ml)
and 0.5% bupivacaine 10 ml+ NSS 1 ml
In operating room patient is monitored with non-
invasive arterial blood pressure,
electrocardiography and pulse oximetry. Supraclavicular brachial plexus block is performed by experienced staff anesthesiologists or anesthetic resident who has experience at least 2 years for brachi
Sponsors
Khonkaen hospital
Khonkaen hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : 1. Patients who has ASA physical status I-II 2. The age between 18 and 75 years 3. Under going for upper extremity surgery (elective or emergency)
Exclusion criteria
Exclusion criteria: Exclusion criteria : patients will be excluded from the study when they 1. Refuse to receive intervention 2. Allergy to the drug under study 3. Have diabetes mellitus 4. Preexist coagulation disorders 5. Were morbid obesity (BMI > 35 kg/m2) 6. Have local infection at the site of the block 7. Have chronic pain 8. Receive medical therapies considered to result in tolerance to opiates 9. Cannot evaluate numerical rating scale 10. Use systemic corticosteroids more than 20 mg/day for 5 days or longer within 12 months 11. Infection (Viral, Active TB)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is duration of sensory block. None Before operation, the patients will be instructed preoperatively about the use of the NRS for pain a | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Time to complete sensory block(Duration from start injection local anesthetic drug to the time wh None evaluate & measurement by nurse | — |
Countries
Thailand
Contacts
Public Contactrattiya witeethep
Khonkaen hospital
Outcome results
None listed